Pharmaceutical Industry Trends - Eli Lilly and Novo Nordisk agreed to offer popular weight loss drugs at drastic discounts [1] - The drugs, including Zepbound and Wegovy, aim to save lives and improve the health of millions of Americans [2] Pricing and Cost Reduction - Eli Lilly and Novo Nordisk are committed to offering Zepbound and Wegovy at most favored nations rates for American patients [2] - Monthly cost of the weight loss drugs will be slashed from $1,350 to $250, representing a significant reduction [2] - Monthly plan costs could be reduced from $1,080 to $346 [3] Political Context - There is a suggestion that the current administration may have facilitated these price reductions [3]